Inhibition of MMP-2 expression affects metabolic enzyme expression levels: Proteomic analysis of rat cardiomyocytes

Journal of Proteomics

Volumn 106, Issue , 2014, Pages 74-85

  Lin, Han Bin ^a   Sharma, Keshav ^a   Bialy, Dariusz ^b   Wawrzynska, Magdalena ^b   Purves, Randy ^c   Cayabyab, Francisco S ^a   Wozniak, Mieczyslaw ^a,b   Sawicki, Grzegorz ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

ATP synthase; Cardiomyocytes; Contractility; Matrix metalloproteinase 2; Metabolic enzymes; SiRNA

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ATP SYNTHASE BETA SUBUNIT; CHAPERONIN 60; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; DIHYDROLIPOYLLYSINE RESIDUE SUCCINYLTRANSFERASE; ELECTRON TRANSFERRING FLAVOPROTEIN; GELATINASE A; MITOCHONDRIAL ENZYME; OXOGLUTARATE DEHYDROGENASE; PROTEOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MATRIX METALLOPROTEINASE INHIBITOR; MMP2 PROTEIN, RAT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENERGY YIELD; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; EXCITATION CONTRACTION COUPLING; GENETIC TRANSFECTION; HEART MUSCLE CELL; INCUBATION TIME; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; RAT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CYTOLOGY; HEART CONTRACTION; MASS SPECTROMETRY; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; PLASMID; SEQUENCE HOMOLOGY; SPRAGUE DAWLEY RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MALE; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE INHIBITORS; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MOLECULAR SEQUENCE DATA; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PLASMIDS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84899817877     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.04.026     Document Type: Article

References (42)

1. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342.
2. Arnsdorf M.F., Sawicki G.J. The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ Res 1981, 49:16-30.
3. Sung M.M., Schulz C.G., Wang W., Sawicki G., Bautista-Lopez N.L., Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 2007, 43:429-436.
4. Wang W., Schulze C.J., Suarez-Pinzon W.L., Dyck J.R., Sawicki G., Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002, 106:1543-1549.
5. Sawicki G., Leon H., Sawicka J., Sariahmetoglu M., Schulze C.J., Scott P.G., et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 2005, 112:544-552.
6. Ali M.A., Cho W.J., Hudson B., Kassiri Z., Granzier H., Schulz R. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 2010, 122:2039-2047.
7. Doroszko A., Polewicz D., Cadete V.J., Sawicka J., Jones M., Szczesna-Cordary D., et al. Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction. Shock 2010, 34:592-600.
8. Ali M.A., Fan X., Schulz R. Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease. Trends Cardiovasc Med 2011, 21:112-118.
9. Barrett A.J., Rawlings N.D., Woessner J.F. Handbook of proteolytic enzymes 2004, Elsvier Academic Press, Amsterdam; Boston. 2nd ed.
10. Hlawaty H., San Juan A., Jacob M.P., Vranckx R., Letourneur D., Feldman L.J. Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2007, 293:H3593-H3601.
11. Light P., Shimoni Y., Harbison S., Giles W., French R.J. Hypothyroidism decreases the ATP sensitivity of KATP channels from rat heart. J Membr Biol 1998, 162:217-223.
12. Bouchard R.A., Clark R.B., Giles W.R. Role of sodium-calcium exchange in activation of contraction in rat ventricle. J Physiol 1993, 472:391-413.
13. Cheung P.Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000, 101:1833-1839.
14. Fert-Bober J., Leon H., Sawicka J., Basran R.S., Devon R.M., Schulz R., et al. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol 2008, 103:431-443.
15. Fert-Bober J., Basran R.S., Sawicka J., Sawicki G. Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury. Proteomics 2008, 8:2543-2555.
16. Sawicki G., Dakour J., Morrish D.W. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 2003, 3:2044-2051.
17. Sawicki G., Jugdutt B.I. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics 2004, 4:2195-2202.
18. Sheoran I.S., Olson D.J., Ross A.R., Sawhney V.K. Proteome analysis of embryo and endosperm from germinating tomato seeds. Proteomics 2005, 5:3752-3764.
19. Pappin D.J., Hojrup P., Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 1993, 3:327-332.
20. Cadete V.J., Sawicka J., Jaswal J.S., Lopaschuk G.D., Schulz R., Szczesna-Cordary D., et al. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2. FEBS J 2012, 279:2444-2454.
21. Polewicz D., Cadete V.J., Doroszko A., Hunter B.E., Sawicka J., Szczesna-Cordary D., et al. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. J Cell Mol Med 2011, 15:1136-1147.
22. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
23. Portbury A.L., Willis M.S., Patterson C. Tearin' up my heart: proteolysis in the cardiac sarcomere. J Biol Chem 2011, 286:9929-9934.
24. Cadete V.J., Arcand S.A., Lin H.B., Sawicki G. Synergistic protection of MLC 1 against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future. Future Med Chem 2013, 5:389-398.
25. Doroszko A., Polewicz D., Sawicka J., Richardson J.S., Cheung P.Y., Sawicki G. Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2. Basic Res Cardiol 2009, 104:669-679.
26. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
27. Eble D.M., Spragia M.L., Ferguson A.G., Samarel A.M. Sarcomeric myosin heavy chain is degraded by the proteasome. Cell Tissue Res 1999, 296:541-548.
28. Lin H.B., Cadete V.J., Sawicka J., Wozniak M., Sawicki G. Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia-reperfusion injury. J Proteomics 2012, 75:5386-5395.
29. Cadete V.J., Sawicka J., Polewicz D., Doroszko A., Wozniak M., Sawicki G. Effect of the Rho kinase inhibitor Y-27632 on the proteome of hearts with ischemia-reperfusion injury. Proteomics 2010, 10:4377-4385.
30. Cadete V.J., Sawicka J., Bekar L.K., Sawicki G. Combined subthreshold dose inhibition of myosin light chain phosphorylation and matrix metalloproteinase-2 activity provides cardioprotection from ischemic/reperfusion injury in isolated rat heart. Br J Pharmacol 2013, 170:380-390.
31. Schulze C.J., Wang W., Suarez-Pinzon W.L., Sawicka J., Sawicki G., Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury. Circulation 2003, 107:2487-2492.
32. Gao C.Q., Sawicki G., Suarez-Pinzon W.L., Csont T., Wozniak M., Ferdinandy P., et al. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res 2003, 57:426-433.
33. Miyazaki K., Hasegawa M., Funahashi K., Umeda M. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 1993, 362:839-841.
34. Morley M.E., Riches K., Peers C., Porter K.E. Hypoxic inhibition of human cardiac fibroblast invasion and MMP-2 activation may impair adaptive myocardial remodelling. Biochem Soc Trans 2007, 35:905-907.
35. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370:61-65.
36. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 2007, 47:211-242.
37. Cauwe B., Opdenakker G. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol 2010, 45:351-423.
38. Zhou H.Z., Ma X., Gray M.O., Zhu B.Q., Nguyen A.P., Baker A.J., et al. Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem Biophys Res Commun 2007, 358:189-195.
39. Cadete V.J., Lin H.B., Sawicka J., Wozniak M., Sawicki G. Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/reperfusion. Proteomics 2012, 12:2366-2377.
40. Zhang H.J., Zhao W., Venkataraman S., Robbins M.E., Buettner G.R., Kregel K.C., et al. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 2002, 277:20919-20926.
41. Nakano Y., Forsprecher J., Kaartinen M.T. Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures. J Cell Physiol 2010, 223:260-269.
42. Covian R., Balaban R.S. Cardiac mitochondrial matrix and respiratory complex protein phosphorylation. Am J Physiol Heart Circ Physiol 2012, 303:H940-H966.